Orca Bio is a biotechnology company dedicated to improving the treatment landscape for patients with blood cancers. By developing high-precision cell therapies, Orca Bio aims to replace compromised blood and immune systems with healthy ones, significantly enhancing survival rates while minimizing the risks associated with traditional allogeneic stem cell transplants. The company's mission is to make these groundbreaking treatments accessible to all patients in need, including potential expansions into autoimmune diseases and genetic blood disorders. Driven by core values of passion, courage, and integrity, Orca Bio fosters a collaborative startup culture where every team member is encouraged to innovate and take calculated risks. The company is committed to excellence in its work, recognizing the profound responsibility that comes with improving patients' quality of life.